PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vita-Salute San Raffaele University, Milano, Italy; Psychiatry & Clinical Psychobiology, Division of Neuroscience, Scientific Institute IRCCS Ospedale San Raffaele, Milano. Electronic address: mazza.mariogennaro@hsr.it.\', \'Vita-Salute San Raffaele University, Milano, Italy; Mood Disorders Unit, Scientific Institute IRCCS Ospedale San Raffaele, Milano, Italy.\', \'Psychiatry & Clinical Psychobiology, Division of Neuroscience, Scientific Institute IRCCS Ospedale San Raffaele, Milano.\', \'Vita-Salute San Raffaele University, Milano, Italy; Division of Immunology, Transplantation and Infectious Diseases, Scientific Institute IRCCS Ospedale San Raffaele, Milano.\', \'Vita-Salute San Raffaele University, Milano, Italy; Psychiatry & Clinical Psychobiology, Division of Neuroscience, Scientific Institute IRCCS Ospedale San Raffaele, Milano.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0924-977X(21)00761-610.1016/j.euroneuro.2021.09.009
?:doi
?:hasPublicationType
?:journal
  • European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34634679
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Rapid response to selective serotonin reuptake inhibitors in post-COVID depression.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all